neurotechnology AI News & Updates
OpenAI Leads $250M Investment in Sam Altman's Brain-Computer Interface Startup Merge Labs
OpenAI has invested in CEO Sam Altman's brain-computer interface startup Merge Labs, leading its $250 million seed round at an $850 million valuation. The company aims to develop non-invasive neural interfaces using molecules and ultrasound to connect humans with AI, competing with Elon Musk's Neuralink. The investment raises concerns about circular dealing, as Merge Labs could function as a "remote control" for OpenAI's software, potentially driving users to OpenAI while increasing the value of Altman's personal holdings.
Skynet Chance (+0.06%): Direct integration of human brains with AI systems creates new pathways for loss of human agency and potential manipulation of neural activity by AI systems. The goal of "merging" humans with superintelligent AI to survive it paradoxically increases dependency and control risks.
Skynet Date (-1 days): The substantial $250M investment and OpenAI's direct involvement accelerates the timeline for human-AI integration, which Altman explicitly frames as necessary for humanity's survival against superintelligent AI. This suggests expectations of advanced AI capabilities arriving sooner than previously anticipated.
AGI Progress (+0.04%): Brain-computer interfaces represent a significant expansion of AI capabilities by providing direct neural data and control mechanisms, potentially accelerating feedback loops between human intelligence and AI systems. OpenAI's commitment to developing AI operating systems that interpret neural signals indicates progress toward more general intelligence applications.
AGI Date (-1 days): The major investment and OpenAI's plans to integrate scientific foundation models with neural interface technology accelerates multiple AGI-relevant research streams simultaneously. The timeline acceleration is evidenced by Altman's 2017 prediction of a merge between 2025-2075, with active development now underway in 2026.